» Articles » PMID: 14499939

Temporal Relationships Between HIV-1 Tat-induced Neuronal Degeneration, OX-42 Immunoreactivity, Reactive Astrocytosis, and Protein Oxidation in the Rat Striatum

Overview
Journal Brain Res
Specialty Neurology
Date 2003 Sep 23
PMID 14499939
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

HIV-1 transactivating protein Tat is neurotoxic and is believed to play a role in the development of AIDS-associated dementia complex. Neurotoxicity of Tat may be associated with oxidative stress. In this study we examined temporal progression of histopathological changes induced by a single microinjection of Tat 1-72 into the rat striatum. Degenerating neural cells, detected by Fluoro-Jade B staining and increased protein oxidation, determined by protein carbonyl immunostaining, were observed in the striatum as soon as 2 h following the microinjection. Further progression of neuronal degeneration was associated with pronounced infiltration of the area surrounding Tat 1-72 injection site by OX-42 positive macrophages/microglia, which was evident at the 24 h time point. Signs of reactive astrocytosis were found in the striatum of Tat 1-72 injected animals as late as 7 days following the single microinjection. Increased GFAP immunoreactivity and changes in the morphology of astrocytes coincided with a second phase of increased protein carbonyl formation, but not with neuronal degeneration. Control polypeptide, nontoxic Tat delta 31-61, did not cause any cell death, inflammatory reaction or oxidative damage. Results of our study support the hypothesis that oxidative stress may be an early step in the mechanism of Tat neurotoxicity.

Citing Articles

Behavioral and histological assessment of a novel treatment of neuroHIV in humanized mice.

Levine A, Thadani C, Soontornniyomkij V, Lopez-Aranda M, Mesa Y, Kitchen S Res Sq. 2024; .

PMID: 38168407 PMC: 10760308. DOI: 10.21203/rs.3.rs-3678629/v1.


Advancing the preclinical study of comorbid neuroHIV and substance use disorders: Current perspectives and future directions.

Namba M, Xie Q, Barker J Brain Behav Immun. 2023; 113:453-475.

PMID: 37567486 PMC: 10528352. DOI: 10.1016/j.bbi.2023.07.021.


Crucial Role of Central Nervous System as a Viral Anatomical Compartment for HIV-1 Infection.

Borrajo A, Svicher V, Salpini R, Pellegrino M, Aquaro S Microorganisms. 2021; 9(12).

PMID: 34946138 PMC: 8705402. DOI: 10.3390/microorganisms9122537.


Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities.

Namba M, Leyrer-Jackson J, Nagy E, Olive M, Neisewander J Front Neurosci. 2021; 15:650785.

PMID: 33935636 PMC: 8082184. DOI: 10.3389/fnins.2021.650785.


HIV-1 Tat Length: Comparative and Functional Considerations.

Mele A, Marino J, Dampier W, Wigdahl B, Nonnemacher M Front Microbiol. 2020; 11:444.

PMID: 32265877 PMC: 7105873. DOI: 10.3389/fmicb.2020.00444.